Literature DB >> 21807081

Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.

Deepak Yadav1, Sachin Survase, Neeraj Kumar.   

Abstract

This study is aimed to develop and evaluate time dependent rupturable multiparticulate pulsatile delivery system for Glipizide. Microcrystalline cellulose (MCC) based pellets containing Glipizide were prepared by extrusion-spheronization technique (Type I pellets). These were further coated with two consecutive layers, a swellable layer of hydroxypropylmethylcellulose (HPMC) and a rupturable layer of plasticized ethylcellulose (EC) with fluidized bed coating to yield Type II pellets. Drug release and water uptake studies were carried out on formulated pellets. SEM was used to monitor the pellets' morphology and change on exposure to dissolution medium. Both types of pellets were evaluated for particle size, flow, friability, dissolution and content uniformity. Immediate release pattern was optimized for Type I pellets to achieve more than 80% drug release within 30 min. Type II pellets displayed burst release and a lag period of 6-8 h. After selection of appropriate proportions of these pellets (Type I and Type II), drug release studies were performed which showed a pulsatile dissolution profile with a lag-time of 6-8 h. Multiparticulate approach with a blend of the two types of pellets was successfully used to develop a pulsatile release product for Glipizide.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807081     DOI: 10.1016/j.ijpharm.2011.07.026

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Prediction of Optimum Combination of Eudragit RS/Eudragit RL/Ethyl Cellulose Polymeric Free Films Based on Experimental Design for Using as a Coating System for Sustained Release Theophylline Pellets.

Authors:  Abbas Akhgari; Ali Tavakol
Journal:  Adv Pharm Bull       Date:  2016-06-30

2.  A novel multi-unit tablet for treating circadian rhythm diseases.

Authors:  Qi Liu; Yinhua Gong; Yun Shi; Liqun Jiang; Chunli Zheng; Liang Ge; Jianping Liu; Jiabi Zhu
Journal:  AAPS PharmSciTech       Date:  2013-05-07       Impact factor: 3.246

3.  Development of floating chitosan-xanthan beads for oral controlled release of glipizide.

Authors:  Nilesh Kulkarni; Pravin Wakte; Jitendra Naik
Journal:  Int J Pharm Investig       Date:  2015 Apr-Jun

4.  Physicochemical properties and drug-release mechanisms of dual-release bilayer tablet containing mirabegron and fesoterodine fumarate.

Authors:  Hong-Goo Lee; Yun-Sang Park; Jin-Hyuk Jeong; Yong-Bin Kwon; Dae Hwan Shin; Ju-Young Kim; Yun-Seok Rhee; Eun-Seok Park; Dong-Wook Kim; Chun-Woong Park
Journal:  Drug Des Devel Ther       Date:  2019-07-23       Impact factor: 4.162

5.  A novel bedtime pulsatile-release caffeine formula ameliorates sleep inertia symptoms immediately upon awakening.

Authors:  Dario A Dornbierer; Firat Yerlikaya; Rafael Wespi; Martina I Boxler; Clarissa D Voegel; Laura Schnider; Aslihan Arslan; Diego M Baur; Markus R Baumgartner; Tina Maria Binz; Thomas Kraemer; Hans-Peter Landolt
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.